Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 02/29/2020 (updated monthly) $1,133.4 (M)
Net Assets - Class A As of 02/29/2020 (updated monthly) $928.4 (M)
P/E Ratio (12-mo Forward)As of 02/29/2020 (updated monthly) 14.97
P/B RatioAs of 02/29/2020 (updated monthly) 5.59

Positions As of 02/29/2020

Portfolio Details

Asset AllocationAs of 02/29/2020

[name] [value]
Equity 95.89%
Cash & Cash Equivalents 4.11%

Geographic BreakdownAs of 02/29/2020

No chart available for this data.
[name] [value]
United States 83.71%
Cash & Cash Equivalents 4.11%
United Kingdom 3.64%
Netherlands 3.15%
Denmark 2.43%
Canada 1.58%
Switzerland 0.78%
Germany 0.59%

sector breakdownAs of 02/29/2020

[name] [value]
Biotechnology 79.56%
Pharmaceuticals 12.20%
Life Sciences Tools & Services 4.13%
Cash & Cash Equivalents 4.11%

TOP TEN HOLDINGSAs of 02/29/2020

46.89%
Other
0% 100%
[holdings-table-heading]
VERTEX PHARMACEUTICALS INC 6.41%
BIOGEN INC 5.93%
AMGEN INC 5.83%
GILEAD SCIENCES INC 5.25%
REGENERON PHARMACEUTICALS INC 5.02%
ILLUMINA INC 4.13%
IOVANCE BIOTHERAPEUTICS INC 4.12%
PTC THERAPEUTICS INC 3.64%
GW PHARMACEUTICALS PLC 3.47%
DECIPHERA PHARMACEUTICALS INC 3.09%